SIS
NVO

Strategic Investment Solutions’s Novo Nordisk NVO Stock Holding History

Strategic Investment Solutions’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.79K Hold
100
– – ﹤0.01% 509
2026
Q1 		$3.67K Sell
100
-265
-73% -$12.6K ﹤0.01% 514
2025
Q4 		$18.6K Hold
365
– – ﹤0.01% 325
2025
Q3 		$20.3K Buy
365
+165
+83% +$9.66K 0.01% 296
2025
Q2 		$24.2K Buy
200
+189
+1,718% +$12.9K 0.01% 276
2025
Q1 		$764 Sell
11
-300
-96% -$24.8K ﹤0.01% 555
2024
Q4 		$32K Buy
311
+300
+2,727% +$32.4K 0.01% 259
2024
Q3 		$1.31K Sell
11
-175
-94% -$23.3K ﹤0.01% 520
2024
Q2 		$24.7K Buy
+186
New +$24.6K 0.01% 243
2023
Q4 		$32.9K Sell
318
-321
-50% -$31.7K 0.01% 567
2023
Q3 		$99.9K Buy
+639
New +$56.3K ﹤0.01% 557

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Strategic Investment Solutions's NVO Position: Q2 2026 in Review

Strategic Investment Solutions held its Novo Nordisk (NVO) position steady in Q2 2026 at 100 shares worth $4.79K. The position accounts for ﹤0.01% of the portfolio, ranked #509.

Strategic Investment Solutions first reported a position in NVO in Q3 2023 and has held it in 11 quarters since. The position peaked at $99.9K in Q3 2023. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Strategic Investment Solutions held 100 shares of Novo Nordisk worth $4.79K as of Q2 2026.
  • Strategic Investment Solutions left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of Strategic Investment Solutions's portfolio in Q2 2026, its #509 holding.
  • Strategic Investment Solutions first reported a position in Novo Nordisk in Q3 2023 and has held it in 11 quarters since.
  • Strategic Investment Solutions's Novo Nordisk position peaked at $99.9K in Q3 2023.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Strategic Investment Solutions's 13F filing for Q2 2026, filed 8 Jul 2026.